Heidi Gray

Lapatinib and potential prognostic value of EGFR mutations in a Gynecologic Oncology Group phase II trial of persistent or recurrent endometrial cancer.

Andrew K Godwin, A. Godwin, K. Leslie, 2012, Gynecologic oncology.

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

George Coukos, Michael N Liebman, Marco Massobrio, 2003, The New England journal of medicine.